HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epidemiological features of pertussis in the United States, 1980-1989.

Abstract
From 1980 through 1989, 27,826 cases of pertussis were reported to the Centers for Disease Control, for an average annual crude incidence of 1.2 cases/100,000 population. The incidence of reported disease increased in all age groups during this period, but the increase was disproportionately large among adolescents and adults. Infants between 1 and 2 months of age were at highest risk for pertussis (average annual incidence, 62.8/100,000). Infants less than 2 months of age had the highest reported rates of pertussis-associated hospitalization (82%), pneumonia (25%), seizures (4%), encephalopathy (1%), and death (1%). Rates of complication were generally higher among unvaccinated children than among those who had received three or more doses of diphtheria-tetanus-pertussis vaccine; 64% of children 3 months to 4 years of age who had reported cases of pertussis had not been immunized appropriately for their age. Whereas control of pertussis in the United States may be further improved through increased levels of diphtheria-tetanus-pertussis vaccination among eligible infants and children, the use of acellular vaccines in adolescents and adults may also be needed to reduce the burden of pertussis in very young infants.
AuthorsK M Farizo, S L Cochi, E R Zell, E W Brink, S G Wassilak, P A Patriarca
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 14 Issue 3 Pg. 708-19 (Mar 1992) ISSN: 1058-4838 [Print] United States
PMID1562663 (Publication Type: Journal Article, Review)
Chemical References
  • Diphtheria-Tetanus-Pertussis Vaccine
  • Erythromycin
Topics
  • Age Factors
  • Diphtheria-Tetanus-Pertussis Vaccine
  • Disease Outbreaks
  • Erythromycin (therapeutic use)
  • Humans
  • Incidence
  • Seasons
  • Sex Factors
  • United States (epidemiology)
  • Whooping Cough (complications, drug therapy, epidemiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: